As of May 2022 Galapagos NV has a market cap of $3.85 Billion. This makes Galapagos NV the world's 2642th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $3.88 B | 6.44% |
2021 | $3.65 B | -43.58% |
2020 | $6.47 B | -52.07% |
2019 | $13.50 B | 169.16% |
2018 | $5.01 B | 4.51% |
2017 | $4.80 B | 61.16% |
2016 | $2.97 B | 20.89% |
2015 | $2.46 B | 331.92% |
2014 | $0.57 B | -8.94% |
2013 | $0.62 B | 10.91% |
2012 | $0.56 B | 58.44% |
2011 | $0.35 B | -16.16% |
2010 | $0.42 B | 66.9% |
2009 | $0.25 B | 148.04% |
2008 | $0.10 B |
On May 17th, 2022 the market cap of Galapagos NV was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $470.54 B | 12,118.39% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $200.55 B | 5,107.62% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $273.51 B | 7,002.14% | ๐บ๐ธ USA |
![]() Sanofi SNY | $132.10 B | 3,330.37% | ๐ซ๐ท France |
![]() Merck MRK | $235.17 B | 6,006.75% | ๐บ๐ธ USA |
![]() Astrazeneca AZN | $203.41 B | 5,181.91% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | $113.65 B | 2,851.14% | ๐ฌ๐ง UK |
![]() Fortress Biotech
FBIO | $0.09 B | -97.47% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $9.32 B | 142.19% | ๐ฎ๐ฑ Israel |